 |
FDA approves ‘osteoporosis’ tabletEffRx Pharmaceuticals has announced that US Food and Drug Administration (FDA) has approved Binosto (alendronate sodium) Effervescent Tablets, previously known as EX101. The tablets are used for the treatment of osteoporosis in postmenopau More… |
Wednesday 2 April 2025
